Google life sciences group to wage war on diabetes

Google will work with drug maker Sanofi on digitizing the process of managing diabetes

Google may still be working on a name for its recently spun off life sciences group, but the division already has a foe: diabetes.

On Monday, Google said the chronic disease will be the first illness the life sciences division focuses on as it becomes a separate business under the new Alphabet holding company.

The search giant also wants to digitize how people manage their diabetes and is partnering with drug maker Sanofi to develop technologies that could aid in that process.

Diabetics use mobile apps, medical devices and even pieces of paper to record food intake, log blood sugar levels, track fitness activities and determine medication doses, Google said. Given the hassles of using these unintegrated methods, only around half of diabetics achieve their target glucose levels, according to a study from The New England Journal of Medicine that was cited by Google.

The medical consequences of not managing diabetes include heart disease, stroke and nerve damage.

Since the partnership is new, neither Google nor Sanofi could say exactly how the search giant's technology could be used by the pharmaceutical company. The goal, though, is to use Google technology including sensors, wearable devices and analytics tools to give doctors and patients more insight into how to better manage diabetes.

For example, the technology could help explain to a physician why a person's glucose level has spiked for several days or provide real-time information related to a patient's insulin dosage or diet.

Google Life Sciences chief Andy Conrad [cq] told Bloomberg smart insulin and measurement devices could come out of the partnership.

The deal's financial terms weren't disclosed.

Google's life sciences group has made other forays into diabetes research. The company is working with drug company Novartis on creating a contact lens that uses tears to measure a person's blood sugar levels. Earlier this month, Google and medical device maker Dexcom said they would collaborate on creating a small sensor that would continuously monitor a person's glucose levels and be connected to the cloud.

Once part of the secretive Google X research lab, the life sciences unit became its own company under a massive reorganization at the search giant. A name hasn't been selected for the new venture.

Join the PC World newsletter!

Error: Please check your email address.

Tags Google

Our Back to Business guide highlights the best products for you to boost your productivity at home, on the road, at the office, or in the classroom.

Keep up with the latest tech news, reviews and previews by subscribing to the Good Gear Guide newsletter.

Fred O'Connor

IDG News Service
Show Comments

Most Popular Reviews

Latest News Articles


GGG Evaluation Team

Kathy Cassidy


First impression on unpacking the Q702 test unit was the solid feel and clean, minimalist styling.

Anthony Grifoni


For work use, Microsoft Word and Excel programs pre-installed on the device are adequate for preparing short documents.

Steph Mundell


The Fujitsu LifeBook UH574 allowed for great mobility without being obnoxiously heavy or clunky. Its twelve hours of battery life did not disappoint.

Andrew Mitsi


The screen was particularly good. It is bright and visible from most angles, however heat is an issue, particularly around the Windows button on the front, and on the back where the battery housing is located.

Simon Harriott


My first impression after unboxing the Q702 is that it is a nice looking unit. Styling is somewhat minimalist but very effective. The tablet part, once detached, has a nice weight, and no buttons or switches are located in awkward or intrusive positions.

Featured Content

Latest Jobs

Don’t have an account? Sign up here

Don't have an account? Sign up now

Forgot password?